| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $68K | — | -86.4% |
| Cost of Revenue | $64K | — | -80.2% |
| Gross Profit | $4K | — | -97.9% |
| R&D Expense | $89K | — | -70.6% |
| SG&A Expense | $3.9M | — | -55.5% |
| Operating Income | -$4.5M | — | +51.4% |
| Net Income | -$16.6M | — | -77.7% |
| EPS (Basic) | -$0.20 | — | +41.2% |
| EPS (Diluted) | -$0.20 | — | +41.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.8M | +6366.8% | — |
| Inventory | $2.4M | +138.1% | — |
| Current Assets | $9.2M | +577.3% | — |
| Total Assets | $11.5M | +217.4% | — |
| Current Liabilities | $7.5M | -28.5% | — |
| Total Liabilities | $8.2M | -41.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | — | -454.8% |
| Investing Cash Flow | -$70K | — | — |
| Financing Cash Flow | $13.3M | — | +1665.6% |
| Stockholders' Equity | $3.3M | +132.4% | +163.0% |